Joint Filing Agreement
Exhibit 99.1
In accordance with Rule 13d-1(f) under the Securities and Exchange Act of 1934, the persons or entities named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of the Issuer and further agree that this joint filing agreement be included as an exhibit to this Schedule 13D. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement as of January 27, 2021.
| XXXXXXX LIFE SCIENCES X, L.P. | ||
| By FHMLS X, L.P., its general partner | ||
| By FHMLS X, L.L.C., its general partner | ||
| By: | * | |
| Xxxxx X. Xxxxxx, Managing Director | ||
| FHMLS X, L.P. | ||
| By FHMLS X, L.L.C., its general partner | ||
| By: | * | |
| Xxxxx X. Xxxxxx, Managing Director | ||
| FHMLS IX, L.L.C. | ||
| By: | * | |
| Xxxxx X. Xxxxxx, Managing Director | ||
| By: | * | |
| Xxxxx X. Xxxxxx | ||
| By: | * | |
| Xxxxxxx Xxxxx | ||
| *By: | /s/ Xxxxx X. Xxxxxx | |
| Xxxxx X. Xxxxxx, as Attorney-in-Fact | ||
This agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on December 17, 2020.
